For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
A heart lung machine is a piece of medical equipment which is designed to take over the function of the heart and lungs during surgery so that a surgeon can operate in a relatively bloodless field on a heart which is not moving. Although this may sound fairly simple, heart lung machines are actually very complex, and it took a great deal of trial and error to develop an effective machine which would address issues like bubbles in the blood, body temperature, and clotting.
The earliest heart lung machines were developed in the 1950s. The technology involves inserting cannulas to divert the blood from the heart to the heart lung machine. As the blood passes through the machine, it is oxygenated and then pumped back into the body. This process is known as cardiopulmonary bypass or simply bypass. Once the surgery is complete, the patient can be taken off bypass to allow the heart and lungs to return to their regular duties.
Heart lung machines can use bubble oxygenation or membrane oxygenation to oxygenate the blood, depending on the design. The device moves the blood through tubes with the use of rollers which put pressure on the tubes, rather than a mechanical pump, to avoid creating bubbles which could injure or kill the patient. The patient must also be given a blood thinner to prevent clotting, as the blood can react with the materials in the tubes and clump up.
This report provides detailed analysis of worldwide markets for Heart Lung Machine System from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Heart Lung Machine System market and further lays out an analysis of the factors influencing the supply/demand for Heart Lung Machine System, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
GCC's report, Global Heart Lung Machine System Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Heart Lung Machine System market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Heart Lung Machine System market are LivaNova (UK), Hemovent (Germany), MAQUET (Germany), Medtronic (USA), Braile Biomedica (Brazil), Terumo Medical (Japan), Tianjin Medical Instrument (China), Guangzhou Landswick (China), among others.
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Heart Lung Machine System industry has been provided.